Medtronic 8-K Details Financials, Officer Changes, and Debt Structure

Ticker: MDT · Form: 8-K · Filed: 2024-02-20T00:00:00.000Z

Sentiment: neutral

Topics: corporate-governance, debt, financial-condition, officer-changes

TL;DR

**Medtronic just dropped an 8-K covering financials, officer changes, and its debt profile, so keep an eye on those senior notes.**

AI Summary

Medtronic plc filed an 8-K on February 20, 2024, reporting its financial condition and results of operations as of February 13, 2024. The filing also detailed compensatory arrangements for certain officers and the departure or election of directors. Key financial instruments mentioned include various senior notes due between 2025 and 2031, indicating ongoing debt management.

Why It Matters

This filing provides investors with an updated snapshot of Medtronic's financial health and leadership, crucial for assessing the company's stability and future direction.

Risk Assessment

Risk Level: low — The 8-K is a routine disclosure of financial condition and corporate governance changes, not indicating immediate high risk.

Key Players & Entities

FAQ

What is the purpose of Medtronic plc's 8-K filing on February 20, 2024?

The 8-K filing by Medtronic plc on February 20, 2024, reports on the company's results of operations and financial condition, details the departure or election of directors and appointment of certain officers, and outlines compensatory arrangements for certain officers, as well as financial statements and exhibits.

What specific financial instruments are mentioned in the filing as of February 13, 2024?

The filing specifically mentions various senior notes, including 'Senior Notes 2019 Due 2025', 'Senior Notes 2020 Due 2025', 'Senior Notes 2022 Due 2025', 'Senior Notes 2019 Due 2027', 'Senior Notes 2020 Due 2028', 'Senior Notes 2022 Due 2028', and 'Senior Notes 2019 Due 2031'.

When was the conformed period of report for this 8-K filing?

The conformed period of report for this 8-K filing was February 13, 2024.

What type of industry does Medtronic plc belong to according to its SIC code?

According to its Standard Industrial Classification (SIC), Medtronic plc belongs to the 'ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]' industry.

What items of information are included in this 8-K filing?

The 8-K filing includes 'Results of Operations and Financial Condition', 'Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers', and 'Financial Statements and Exhibits'.

From the Filing

0001613103-24-000006.txt : 20240220 0001613103-24-000006.hdr.sgml : 20240220 20240220064701 ACCESSION NUMBER: 0001613103-24-000006 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 17 CONFORMED PERIOD OF REPORT: 20240213 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240220 DATE AS OF CHANGE: 20240220 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Medtronic plc CENTRAL INDEX KEY: 0001613103 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 000000000 FISCAL YEAR END: 0426 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-36820 FILM NUMBER: 24650640 BUSINESS ADDRESS: STREET 1: 20 ON HATCH, LOWER HATCH STREET CITY: DUBLIN STATE: L2 ZIP: 2 BUSINESS PHONE: 01135314381700 MAIL ADDRESS: STREET 1: 20 ON HATCH, LOWER HATCH STREET CITY: DUBLIN STATE: L2 ZIP: 2 FORMER COMPANY: FORMER CONFORMED NAME: Medtronic Ltd DATE OF NAME CHANGE: 20150112 FORMER COMPANY: FORMER CONFORMED NAME: Medtronic Holdings Ltd DATE OF NAME CHANGE: 20140711 FORMER COMPANY: FORMER CONFORMED NAME: Kalani I Ltd DATE OF NAME CHANGE: 20140709 8-K 1 mdt-20240213.htm 8-K mdt-20240213 0001613103 D02 XH02 false 0001613103 2024-02-13 2024-02-13 0001613103 us-gaap:CommonStockMember 2024-02-13 2024-02-13 0001613103 mdt:SeniorNotes2019Due2025Member 2024-02-13 2024-02-13 0001613103 mdt:SeniorNotes2020Due2025Member 2024-02-13 2024-02-13 0001613103 mdt:SeniorNotes2022Due2025Member 2024-02-13 2024-02-13 0001613103 mdt:SeniorNotes2019Due2027Member 2024-02-13 2024-02-13 0001613103 mdt:SeniorNotes2020Due2028Member 2024-02-13 2024-02-13 0001613103 mdt:SeniorNotes2022Due2028Member 2024-02-13 2024-02-13 0001613103 mdt:SeniorNotes2019Due20311.625PercentMember 2024-02-13 2024-02-13 0001613103 mdt:SeniorNotes2019Due20311.00PercentMember 2024-02-13 2024-02-13 0001613103 mdt:SeniorNotes2022Due2031Member 2024-02-13 2024-02-13 0001613103 mdt:SeniorNotes2020Due2032Member 2024-02-13 2024-02-13 0001613103 mdt:SeniorNotes2022Due2034Member 2024-02-13 2024-02-13 0001613103 mdt:SeniorNotes2019Due20392.250PercentMember 2024-02-13 2024-02-13 0001613103 mdt:SeniorNotes2019Due20391.50PercentMember 2024-02-13 2024-02-13 0001613103 mdt:SeniorNotes2020Due2040Member 2024-02-13 2024-02-13 0001613103 mdt:SeniorNotes2019Due2049Member 2024-02-13 2024-02-13 0001613103 mdt:SeniorNotes2020Due2050Member 2024-02-13 2024-02-13 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   _____________________________  FORM 8-K   _____________________________  CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 13, 2024   _____________________________  Medtronic plc (Exact name of Registrant as Specified in its Charter)    _____________________________    Ireland   1-36820   98-1183488 (State or other jurisdiction of incorporation)   (Commission File Number)   (IRS Employer Identification No.) 20 On Hatch, Lower Hatch Street Dublin 2 , Ireland (Address of principal executive offices) (Zip Code) + 353 1 438-1700 (Registrant’s telephone number, including area code) Not Applicable Former name or former address, if changed since last report Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(

View on Read The Filing